Harvard Bioscience
HBIO
#8485
Rank
HK$0.91 B
Marketcap
HK$20.97
Share price
-1.10%
Change (1 day)
-37.73%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of June 2024 : HK$31.55 M

According to Harvard Bioscience's latest financial reports the company has HK$31.55 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$33.45 M-5.03%
2022-12-31HK$35.22 M-42.24%
2021-12-31HK$60.98 M-5.43%
2020-12-31HK$64.48 M-0.67%
2019-12-31HK$64.92 M1.44%
2018-12-31HK$63.99 M57.77%
2017-12-31HK$40.56 M-6.52%
2016-12-31HK$43.39 M-16.98%
2015-12-31HK$52.26 M-52.34%
2014-12-31HK$0.10 B-45.13%
2013-12-31HK$0.19 B24.67%
2012-12-31HK$0.16 B15.2%
2011-12-31HK$0.13 B-9.24%
2010-12-31HK$0.15 B19.18%
2009-12-31HK$0.12 B21.17%
2008-12-31HK$0.10 B-23.96%
2007-12-31HK$0.13 B91.85%
2006-12-31HK$72.77 M22.98%
2005-12-31HK$59.17 M-39.04%
2004-12-31HK$97.07 M52.06%
2003-12-31HK$63.84 M-46.55%
2002-12-31HK$0.11 B-47.88%
2001-12-31HK$0.22 B-17.98%
2000-12-31HK$0.27 B1400.7%
1999-12-31HK$18.61 M151.06%
1998-12-31HK$7.41 M